Commentary on “European collaboration in trials of new agents for children with cancer” by Ablett et al.
Authors:
- Malcolm A SmithMSMalcolm A Smith
- Barry D AndersonBABarry D Anderson
- 31 August 2004
- journal article
- editorial
- Published by Elsevier in European Journal of Cancer
- Vol. 40 (12) , 1893-1895
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cisplatin-induced cytotoxicity is blocked by brain-derived neurotrophic factor activation of TrkB signal transduction path in neuroblastomaCancer Letters, 2003
- Regulatory Approvals of Pediatric Oncology Drugs: Previous Experience and New InitiativesJournal of Clinical Oncology, 2003
- IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedsideExpert Opinion on Biological Therapy, 2002
- Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkBMedical and Pediatric Oncology, 2001
- Synergistic Cytotoxicity in Solid Tumor Cell Lines Between N-(4-Hydroxyphenyl)retinamide and Modulators of Ceramide MetabolismJNCI: Journal of the National Cancer Institute, 2000
- Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugsInternational Journal of Cancer, 2000
- Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCNNature Medicine, 2000
- Antitumour activity of oxaliplatin in neuroblastoma cell linesEuropean Journal of Cancer, 1999